ABSTRACT OBJECTIVES
rates of 40% to 60% at 12 months limit its long-term durability (3, 4) . Arterial restenosis after PTA is a difficult problem to solve, requiring further attempts at revascularization with associated poorer clinical outcomes and increased cost (5) . The mechanisms underlying vascular restenosis are complex but may include inflammation and calcification (6) . Currently, we are unable to predict which patients will experience restenosis.
Positron emission tomography (PET) is a clinically available molecular imaging method that produces quantitative images of the distribution of a radiolabelled molecule. Such images can be co-registered with computed tomography (CT) to provide a topographical distribution of activity. 18 
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A P R I L 2 0 2 0 : 1 0 0 8 -1 7 between 18 F-FDG, 18 F-NaF, and risk factors were examined using Spearman rank correlation coefficients (nonparametric data). Intra-class correlation coefficients were calculated to assess average intra-observer (1-way random effects model) and 
See the Supplemental Appendix for further statistical methodology.
RESULTS
A total of 86 patients were identified as eligible for enrollment. Fifty-five patients were eligible for inclusion and 50 patients agreed to participate (Supplemental Table 1 ). Ten patients did not complete the study protocol because of the following: stenting performed due to a suboptimal PTA (n ¼ 5), patient withdrawal from the study before the 6-week scan (n ¼ 3), and no angioplasty performed because of an unfavorable lesion profile at the time of angioplasty (n ¼ 2).
Subsequent results, therefore, refer to the 40 patients who successfully completed the study protocol (Table 1) 
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Symptom recurrence included stable claudication (n ¼ 7), worsening claudication (n ¼ 5), and worsening pain with non-healing ulcer (n ¼ 2). In the norestenosis group, 4 people developed symptoms during follow-up, which was manifest by a deterioration of walking distance.
The predictive value of both 18 F-FDG (with a cutoff TBR max value of 1.98) and 18 F-NaF (with a cut-off TBR max value of 2.11) PET was highly discriminatory for the occurrence of restenosis at 1 year (p < 0.0001, log-rank p < 0.001) (Figure 3 ). In contrast, there was no difference in the index lesion calcium score between those who did or did not develop restenosis Mann-Whitney U test used for comparisons. Dots are actual median TBR max values per patient, bars demonstrate median þ interquartile range. **p < 0.001, *p <0.05.
TBR max ¼ target-to-background ratio maximum; other abbreviations as in Figure 1 .
Chowdhury et al. increasing role in the lower limb. These data will require prospective external validation, and the generalizability of the current findings is limited by the modest sample size and single-center setting.
CONCLUSIONS
Noninvasive molecular imaging using 18 
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